Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Prolonged response to first-line erlotinib for advanced lung adenocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1634/theoncologist.10-90003-1
10.1634/theoncologist.10-90003-1 · 2005 · External reference
10.1016/j.lungcan.2005.11.001
10.1016/j.lungcan.2005.11.001 · 2006 · External reference
10.1056/nejmoa050753
10.1056/nejmoa050753 · 2005 · External reference
10.1200/jco.2006.05.8073
10.1200/jco.2006.05.8073 · 2006 · External reference
10.1634/theoncologist.11-6-655
10.1634/theoncologist.11-6-655 · 2006 · External reference
10.1158/1078-0432.ccr-06-0260
10.1158/1078-0432.ccr-06-0260 · 2006 · External reference
10.1200/jco.2006.07.5754
10.1200/jco.2006.07.5754 · 2007 · External reference
10.1200/jco.2006.24.18_suppl.7178
10.1200/jco.2006.24.18_suppl.7178 · 2006 · External reference
10.1200/jco.2005.04.3299
10.1200/jco.2005.04.3299 · 2006 · External reference
10.3816/clc.2006.n.022
10.3816/clc.2006.n.022 · 2006 · External reference
10.1200/jco.2005.08.409
10.1200/jco.2005.08.409 · 2005 · External reference
10.1056/nejmoa050736
10.1056/nejmoa050736 · 2005 · External reference
Unresolved reference
2006 · External reference
10.1634/theoncologist.12-5-610
10.1634/theoncologist.12-5-610 · 2007 · External reference
10.1136/bmj.317.7161.771
10.1136/bmj.317.7161.771 · 1998 · External reference
